Conversely, the level of transglutaminase 1 (TGM1), an enzyme involved in epidermal barrier formation, is increased in keratinocytes of TOC patients, suggesting they potentially have increased epidermal barrier function [38]. The gene discussed is TGM1; the disease is palmoplantar keratoderma-esophageal carcinoma syndrome.